Covington Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$59K Buy
1,525
+57
+4% +$2.29K ﹤0.01% 539
2022
Q2
$55K Sell
1,468
-99
-6% -$4.03K ﹤0.01% 548
2022
Q1
$69K Hold
1,567
﹤0.01% 536
2021
Q4
$67K Hold
1,567
﹤0.01% 504
2021
Q3
$68K Buy
1,567
+867
+124% +$38.4K ﹤0.01% 503
2021
Q2
$30K Sell
700
-97
-12% -$4.08K ﹤0.01% 612
2021
Q1
$31K Buy
797
+22
+3% +$833 ﹤0.01% 536
2020
Q4
$28K Buy
775
+75
+11% +$2.7K ﹤0.01% 528
2020
Q3
$27K Sell
700
-1,000
-59% -$38.5K ﹤0.01% 505
2020
Q2
$60K Hold
1,700
﹤0.01% 422
2020
Q1
$55K Sell
1,700
-233
-12% -$9.1K ﹤0.01% 400
2019
Q4
$87K Buy
1,933
+233
+14% +$9.75K ﹤0.01% 396
2019
Q3
$69K Sell
1,700
-655
-28% -$27.8K ﹤0.01% 395
2019
Q2
$101K Sell
2,355
-500
-18% -$19.2K 0.01% 348
2019
Q1
$110K Buy
2,855
+155
+6% +$5.92K 0.01% 322
2018
Q4
$95K Buy
2,700
+2,000
+286% +$72.5K 0.01% 331
2018
Q3
$27K Sell
700
-316
-31% -$11K ﹤0.01% 493
2018
Q2
$33K Hold
1,016
﹤0.01% 477
2018
Q1
$28K Hold
1,016
﹤0.01% 494
2017
Q4
$25K Hold
1,016
﹤0.01% 546
2017
Q3
$30K Buy
+1,016
New +$28.1K ﹤0.01% 491

Other funds holding BSX

Covington Capital Management's BSX Position: Q3 2022 in Review

Covington Capital Management increased its Boston Scientific (BSX) stake by 3.9% in Q3 2022, buying an estimated $2.29K and bringing the position to 1,525 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Covington Capital Management first reported a position in BSX in Q3 2017 and has held it in 21 quarters since. The position peaked at $110K in Q1 2019. 865 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Covington Capital Management held 1,525 shares of Boston Scientific worth $59K as of Q3 2022.
  • Covington Capital Management bought 57 Boston Scientific shares in Q3 2022, an estimated $2.29K.
  • Boston Scientific made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #539 holding.
  • Covington Capital Management first reported a position in Boston Scientific in Q3 2017 and has held it in 21 quarters since.
  • Covington Capital Management's Boston Scientific position peaked at $110K in Q1 2019.
  • 865 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.